Plants and therapeutics: Interaction

<p>Medicinal herbs are getting popularity due to their good compliance on the basis of their ethnic utilization and lesser side effects. Plasma lipids in body include, cholesterol, triglycerides, very low density lipoprotein-cholesterol, low density lipoprotein-cholesterol, and high density li...

Full description

Saved in:
Bibliographic Details
Main Authors: Shah Murad (Author), Hafiz Moeen- (Author), Farid- (Author), Abdul Ghaffar (Author), Seema Shah Murad (Author), Jamila Shah (Author), Manal Rauf Mahar (Author)
Format: Book
Published: International Journal of Pharmaceutical Sciences and Developmental Research - Peertechz Publications, 2019-12-31.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_ijpsdr_000022
042 |a dc 
100 1 0 |a Shah Murad  |e author 
700 1 0 |a  Hafiz Moeen-  |e author 
700 1 0 |a  Farid-  |e author 
700 1 0 |a  Abdul Ghaffar  |e author 
700 1 0 |a  Seema Shah Murad  |e author 
700 1 0 |a  Jamila Shah  |e author 
700 1 0 |a Manal Rauf Mahar  |e author 
245 0 0 |a Plants and therapeutics: Interaction 
260 |b International Journal of Pharmaceutical Sciences and Developmental Research - Peertechz Publications,   |c 2019-12-31. 
520 |a <p>Medicinal herbs are getting popularity due to their good compliance on the basis of their ethnic utilization and lesser side effects. Plasma lipids in body include, cholesterol, triglycerides, very low density lipoprotein-cholesterol, low density lipoprotein-cholesterol, and high density lipoprotein-cholesterol. High levels of LDL-cholesterol and lower levels of HDL-cholesterol may cause oxidation in plasma leading to formation of atherogenic plaques which are main etiological factors for development of Coronary Artery Diseases (CAD). Many hypolipidemic herbs are being used to prevent CAD. We have used AJWAIN, Alsi separately and in combination to observe their hypolipidemic potential. Study was conducted at Jinnah Hospital Lahore-Pakistan from March 2015 to July 2015. One hundred hyperlipidemic patients were selected from lipid research clinic of Jinnah Hospital, Lahore-Pakistan, and approved written consent was taken from all patients. They were divided in four equal groups comprising 25 patients in each group. Group-I was treated by AJWAIN for three months, Group-II was treated by ALSI, Group-III was treated by AJWAIN plus Alsi for the period of three months. After three months therapy it was observed that AJWAIN reduced LDL-cholesterol 23.77mg/dl and increased HDL-cholesterol 3.3mg/dl. ALSI reduced LDL-cholesterol 7.5mg/dl and increased HDL-cholesterol 5.3mg/dl. Whereas combination of both agents decreased LDL-cholesterol 16.1mg/dl and increased HDL-cholesterol 6.6mg/dl in three months therapy. It was concluded from this research work that ALSI and AJWAIN given separately or in combination, have good enough potential to reduce LDL-cholesterol but are less potent effect on HDL-cholesterol in hyperlipidemic patients. </p> 
540 |a Copyright © Shah Murad et al. 
546 |a en 
655 7 |a Research Article  |2 local 
856 4 1 |u https://doi.org/10.17352/ijpsdr.000022  |z Connect to this object online.